Analyst Reco. Novo Nordisk A/S

Equities

NOVO B

DK0062498333

Pharmaceuticals

Real-time Estimate Cboe Europe Other stock markets 07:48:17 15/01/2026 pm IST			5-day change	1st Jan Change
373.20 ^DKK	-1.34%		+0.68%	+14.63%

07:40pm	Novo Nordisk Foundation Grants $856 Million to BioInnovation Institute to Boost Innovation in Denmark, Europe	MT
07:15pm	Novo Nordisk Foundation Pledges Up to DKK5.5 Billion for Denmark's BioInnovation Institute	MT

Analyst Reco.

06:54pm	NOVO NORDISK : Barclays reiterates its Neutral rating	ZD
03:21pm	NOVO NORDISK : UBS reiterates its Neutral rating	ZD
01:13pm	NOVO NORDISK : Buy rating from JP Morgan	ZD
01:09pm	UBS Raises Target Price for Novo Nordisk to 390 Danish Kroner (from 295), Reiterates Neutral Rating	FW
13/01	Danske Bank Lowers Price Target for Novo Nordisk to 455 Danish Kroner (from 480), Reiterates Buy - BN	FW
12/01	NOVO NORDISK : Gets a Buy rating from Berenberg	ZD
10/01	Sector Update: Consumer Stocks Gain Late Afternoon	MT
09/01	CICC Initiates Coverage on Novo Nordisk with Outperform Rating and $73.50 Price Target for U.S. ADR - BN	FW
08/01	NOVO NORDISK : Berenberg reaffirms its Buy rating	ZD
07/01	NOVO NORDISK : Barclays reiterates its Neutral rating	ZD
06/01	Sector Update: Health Care Stocks Decline Late Afternoon	MT
05/01	Global markets live: Disney, Comcast, Chevron, Kosmos Energy, Novo Nordisk…
05/01	NOVO NORDISK : JP Morgan gives a Buy rating	ZD
05/01	Novo Nordisk Begins Selling Wegovy Tablet to Self-Paying Patients in the US (R)	FW
05/01	Novo Nordisk Begins Selling Wegovy Pill to Self-Paying Patients in the US	FW
23/12	Novo Nordisk Surges After U.S. Approval of Wegovy Pill – Analysts Weigh In	FW
16/12	NOVO NORDISK : JP Morgan keeps its Buy rating	ZD
16/12	NOVO NORDISK : Receives a Buy rating from Deutsche Bank	ZD
16/12	DNB Carnegie lowers its target price for Novo Nordisk to DKK 440 (445), reiterates buy recommendation	FW
15/12	NOVO NORDISK : UBS reiterates its Neutral rating	ZD
15/12	Kepler reiterates its buy recommendation for Novo Nordisk – top sector pick	FW
15/12	Kepler Cheuvreux lowers its target price for Novo Nordisk to DKK 430 (510), reiterates buy recommendation	FW
12/12	Novo Nordisk steady amid Lilly Retatrutide risks
12/12	Nykredit lowers target price for Novo Nordisk to 400 Danish kroner (450), reiterates buy - BN	FW
12/12	NOVO NORDISK : Deutsche Bank reiterates its Buy rating	ZD